FDA approves CSL’s prophylactic for severe swelling condition

CSL Behring won FDA approval on Monday for its once-monthly preventive treatment for a rare, genetic condition that causes swelling episodes. Andembry is approved to prevent attacks of hereditary angioedema, also ...